Document is current
Any future updates will be listed below
-
Authors
Willenbrock, Frances
Cox, Catrin M.
Parkes, Eileen E.
Wilhelm-Benartzi, Charlotte S.
Abraham, Aswin G.
Owens, Robert
Sabbagh, Ahmad
Jones, Christopher M.
Hughes, Daniel L. I.
Maughan, Tim
Hurt, Christopher N. http://orcid.org/0000-0003-1206-8355
O’Neill, Eric E.
Mukherjee, Somnath
-
Funding
Funding for this research was provided by:
Cancer Research UK
DH | National Institute for Health Research
- License Information
-
More Information
Article History
Received: 11 June 2020
Revised: 30 September 2020
Accepted: 2 October 2020
First Online: 26 October 2020
Ethics approval and consent to participate
: The trial protocol was approved by the UK Medicines and Healthcare Products Regulatory Agency and a multicentre research ethics committee. Written informed consent was obtained for all patients who participated in SCALOP, as well as for the optional translational sample collection component. The study was performed in accordance with the Declaration of Helsinki.
: No relevant identifiable patient data.
: Anonymised data available on request from the corresponding author.
: The authors declare no competing interests.
: C.C., C.W.B. and C.N.H. are supported by Cancer Research UK Clinical Trials Unit core funding. C.M.J. is supported by a Wellcome Trust Clinical Research Fellowship. E.O.N. receives funding from the Kidani Memorial Trust and Cancer Research UK. S.M. is supported by funding from the NIHR Oxford Biomedical Research Centre.
